Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Blincyto“
Suchtreffer
Begriffe & Kennungen
Blincyto · 4.8 · Capillary leak syndrome was observed in 1 patient in the phase II clinical study in adult patients with Philad
Eintrag öffnenBlincyto · 4.8 · Cytokine release syndrome (CRS)
Eintrag öffnenBlincyto · 4.8 · Cytokine release syndrome was reported in 15.6% of adult patients with CD19-positive B-cell precursor ALL in t
Eintrag öffnenBlincyto · 4.8 · Cytokine release syndrome was reported in 2.9% of adult patients with MRD positive B-cell precursor ALL (N = 1
Eintrag öffnenBlincyto · 4.8 · Description of selected adverse reactions
Eintrag öffnenBlincyto · 4.8 · Elderly patients with MRD positive ALL treated with BLINCYTO may have an increased risk of hypogammaglobulinae
Eintrag öffnenBlincyto · 4.8 · Elevated liver enzyme events were reported for 12.4% of adult patients with MRD positive B-cell precursor ALL
Eintrag öffnenBlincyto · 4.8 · Elevated liver enzyme events were reported for 17.8% of adult patients with Philadelphia chromosome-positive r
Eintrag öffnenBlincyto · 4.8 · Elevated liver enzyme events were reported in 15.6% of adult patients with CD19-positive B-cell precursor ALL
Eintrag öffnenBlincyto · 4.8 · Elevated liver enzymes
Eintrag öffnenBlincyto · 4.8 · Event terms that represent the same medical concept or condition were grouped together and reported as a singl
Eintrag öffnenBlincyto · 4.8 · For clinical management of CRS, see section 4.4.
Eintrag öffnenBlincyto · 4.8 · For clinical management of elevated liver enzymes, see section 4.4.
Eintrag öffnenBlincyto · 4.8 · For clinical management of infections, see section 4.4.
Eintrag öffnenBlincyto · 4.8 · For clinical management of neurologic events and ICANS, see section 4.2.
Eintrag öffnenBlincyto · 4.8 · ICANS, including Grade 3 and higher ICANS, were reported in clinical trials and with post-marketing experience
Eintrag öffnenBlincyto · 4.8 · In clinical studies of adult ALL patients treated with BLINCYTO, less than 2% tested positive for anti-blinatu
Eintrag öffnenBlincyto · 4.8 · In the randomised phase III clinical study (N = 267) and the single-arm phase II clinical study (N = 189) in p
Eintrag öffnenBlincyto · 4.8 · In the randomised phase III clinical study (N = 267) and the single-arm phase II clinical study (N = 189) in p
Eintrag öffnenBlincyto · 4.8 · In the randomised phase III clinical study (N = 267) and the single-arm phase II clinical study (N = 189) in p
Eintrag öffnen